Patients in France are increasingly forgoing essential dental care due to high out-of-pocket costs, with some opting to avoid procedures like dental implants despite medical recommendations, according to recent reports. Damien, a 67-year-old retiree in the Tarn, and Emeline, a 37-year-old mother of twins, describe how financial barriers have forced them to delay or abandon treatments critical to their health, highlighting broader concerns about healthcare affordability in the country.
Why Are Dental Implants Costing Patients in France?
Dental implants, a common solution for missing teeth, can cost significant amounts per procedure in France, with additional fees for consultations and follow-up care. Damien, who has diabetes and relies on a network of specialists, faced a €3,600 bill after his dentist recommended an implant following repeated crown failures. “I couldn’t afford it,” he said, noting that his previous dentist’s consultation—charged €125 and not reimbursed—added to the burden. Similar costs plague Emeline, who requires implants to address a decade-old dental gap that has led to chronic pain. “Each implant costs €1,200 out-of-pocket, which is impossible for me,” she said.
According to the French National Health Insurance (Assurance Maladie), dental care is among the most expensive sectors for patients, with out-of-pocket expenses representing a substantial portion of total costs—far higher than for other medical services. While some procedures are partially covered under long-term illness (Affection de Longue Durée, or ALD) programs, implants are typically excluded, leaving patients to bear the full cost.

What Are the Health Consequences of Avoiding Dental Care?
The decision to forgo treatment has tangible health impacts. Emeline, who lost three teeth in her 20s, now suffers from chronic cervical-brachial neuralgia due to uneven chewing patterns. “I’ve been in pain for eight years, and no doctor can help until I fix my mastication,” she said. Her condition has forced her to rely on chiropractic care, a non-conventional treatment not covered by public health insurance.
Damien, meanwhile, continues to use a temporary solution for his failing crown, despite concerns about long-term complications. “I know it’s not ideal, but I can’t justify spending €3,000 to €4,000 on a tooth at my age,” he said. Dental experts warn that untreated dental issues can lead to broader health risks, including infections, nutritional deficiencies, and exacerbated chronic conditions like diabetes. A 2022 study in *The Lancet* found that poor oral health is linked to an increased risk of cardiovascular disease, underscoring the importance of accessible dental care.

How Are French Patients Responding to Rising Costs?
Efforts to address the issue are underway. In 2023, the French government proposed capping out-of-pocket expenses for specialist consultations, including dentists, as part of broader healthcare reforms. The Assurance Maladie also released a report in June 2024 outlining plans to reduce patient costs by expanding coverage for preventive dental care. However, advocates argue that more needs to be done.
“Dental care isn’t a luxury—it’s a necessity,” said Emeline. “You can’t function properly if you can’t eat or speak without pain.” Meanwhile, Damien, who has benefited from ALD coverage for his diabetes, expressed frustration over the disparity. “I had no issues with my cancer treatment, but dental care is a different story.”
What Solutions Are Being Explored?
Proposals to improve access include expanding public subsidies for dental implants and increasing the number of state-funded dental clinics. The French Dental Council (CNOM) has also called for greater transparency in pricing, citing “significant variations” in costs across regions.
For now, patients like Damien and Emeline remain caught between medical necessity and financial reality. As France debates healthcare reform, their stories highlight the urgent need to balance cost control with equitable access to essential services.

- Understanding Childhood Cancer Treatment and Chemotherapy Success
- Ask Your Medical Science Questions to NPR
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- Why Placebos Still Work Even When Patients Know They're Fake (daybreakwire.com)